|
|||||
|
|
FDA perspective on the need for revised performance goals for evaluating stenting of femoropopliteal arteries |
|
| Authors: | Lindsay K. Pack BSE Donna C. Buckley MD MS Jennifer L. Goode BS Steven S. Brooks MD Lisa M. Lim PhD |
| Affiliation: | Food and Drug Administration, Center for Devices and Radiological Health, Office of Device Evaluation, Silver Spring, Maryland |
| Abstract: | |
| Keywords: | |